251 / 294
251
Biophysical Society 59
th
Annual Meeting, Baltimore, Maryland
Authors of submitted abstracts completed a disclosure statement. Disclosures included any relationships that may bias one’s
presentation or which, if known, could give the perception of bias. These situations include but are not limited to:
1. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
2. Research funded by industry grant
3. Employment (full- or part-time) in funding company
4. Ownership or Partnership in funding organization
5. Consulting fees or other remuneration from industry
6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson in company
7. Receipt of royalties from referenced company products
8. Speaker’s bureau
9. Other
Below is the list of authors and disclosures for programmed abstracts.
Author Disclosures
Name
Disclosure Entity
Disclosure Type
Presentation Number
Aldeghi, Matteo
Evotec (U.K.) Ltd.
Research funded by industry grant
1791-Plat
Alvaro, Giuseppe
Autifony Therapeutics Limited Employment (full or part-time) in funding company 635-Pos
Amuzescu, Bogdan
Cytocentrics Bioscience GmbH Employment (full or part-time) in funding company 2954-Pos
Anantharaman, Thomas
BioNano Genomics
Employment (full or part-time) in funding company 742-Pos
Andrzejewska, Weronika
grant (UMO-2011/01/B/
ST5/00846) fromNational
Science Centre
Other
1972-Pos
Anson, Blake
CDI
Employment (full or part-time) in funding company 3014-Pos
Aoyama, Natsuyo
CDI
Employment (full or part-time) in funding company 3014-Pos
Armstrong, Luke
ChanTest
Employment (full or part-time) in funding company 2955-Pos
Baddeley, David
Zeiss
Receipt of royalties from referenced company
products
2393-Pos
Barker, John
Evotec (U.K.) Ltd.
Employment (full or part-time) in funding company 1791-Plat
Bayley, Hagan
Oxford Nanopore Technologies Non-remunerative positions of influence such as
officer, board member, trustee, or public spokesper-
son in company
935-Plat
Beattie, Kylie
GlaxoSmithKline
Research funded by industry grant
605-Pos
Belardinelli, Luiz
Gilead Sciences
Employment (full or part-time) in funding company 1395-Pos
Benjamin, Christopher
Pandion Laboratories LLC Research funded by industry grant
3115-Pos
Benner, Steven
Firebird Molecular Sciences
Receipt of royalties from referenced company
products
1985-Pos
Berne, Bruce
Schrodinger Inc
Consulting fees or other remuneration from industry 60-Plat
Bers, Donald
Gilead Sciences
Research funded by industry grant
981-Plat
Bett, Glenna
Cytocybernetics
Ownership or Partnership in funding organization 560-Pos
Bett, Glenna
Cytocybernetics
Ownership or Partnership in funding organization 561-Pos
Bett, Glenna
Cytocybernetics
Ownership or Partnership in funding organization 1366-Pos
Bewersdorf, Joerg
Bruker Corporation
Consulting fees or other remuneration from industry 2398-Pos